ORIC Oric Pharmaceuticals Inc

Price (delayed)

$17.25

Market cap

$633.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.64

Enterprise value

$528.8M

Highlights
The quick ratio has surged by 118% year-on-year and by 11% since the previous quarter
The EPS has soared by 83% year-on-year and by 21% since the previous quarter
ORIC's net income has dropped by 174% year-on-year and by 10% since the previous quarter
Oric Pharmaceuticals's equity has decreased by 4.7% QoQ

Key stats

What are the main financial stats of ORIC
Market
Shares outstanding
36.7M
Market cap
$633.01M
Enterprise value
$528.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.29
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$81.34M
EBITDA
-$80.39M
Free cash flow
-$52.74M
Per share
EPS
-$2.64
Free cash flow per share
-$1.44
Book value per share
$7.52
Revenue per share
$0
TBVPS
$7.74
Balance sheet
Total assets
$283.96M
Total liabilities
$7.89M
Debt
$0
Equity
$276.08M
Working capital
$272.43M
Liquidity
Debt to equity
0
Current ratio
36.49
Quick ratio
36.24
Net debt/EBITDA
1.3
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-33.3%
Return on equity
-34.4%
Return on invested capital
-64.4%
Return on capital employed
-29.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ORIC stock price

How has the Oric Pharmaceuticals stock price performed over time
Intraday
-2.6%
1 week
-11.31%
1 month
-3.85%
1 year
-26.75%
YTD
-49.04%
QTD
-2.49%

Financial performance

How have Oric Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$81.56M
Net income
-$81.34M
Gross margin
N/A
Net margin
N/A
ORIC's net income has dropped by 174% year-on-year and by 10% since the previous quarter
The operating income has dropped by 160% year-on-year and by 10% since the previous quarter

Growth

What is Oric Pharmaceuticals's growth rate over time

Valuation

What is Oric Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 83% year-on-year and by 21% since the previous quarter
The stock's P/B is 44% less than its last 4 quarters average of 4.1
Oric Pharmaceuticals's equity has decreased by 4.7% QoQ

Efficiency

How efficient is Oric Pharmaceuticals business performance
Oric Pharmaceuticals's return on invested capital has surged by 98% YoY and by 27% QoQ
The return on equity is up by 33% since the previous quarter
The ROA is up by 12% since the previous quarter and by 4.9% year-on-year

Dividends

What is ORIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ORIC.

Financial health

How did Oric Pharmaceuticals financials performed over time
The quick ratio has surged by 118% year-on-year and by 11% since the previous quarter
The company's current ratio has surged by 117% YoY and by 11% QoQ
ORIC's debt is 100% smaller than its equity
Oric Pharmaceuticals's equity has decreased by 4.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.